Published in Viruses on December 19, 2011
XMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model? PLoS One (2012) 0.81
Detection of viral proteins in human cells lines by xeno-proteomics: elimination of the last valid excuse for not testing every cellular proteome dataset for viral proteins. PLoS One (2014) 0.78
Prevalence and characterization of murine leukemia virus contamination in human cell lines. PLoS One (2015) 0.76
Clustal W and Clustal X version 2.0. Bioinformatics (2007) 126.47
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood (1975) 15.95
NCBI GEO: archive for functional genomics data sets--10 years on. Nucleic Acids Res (2010) 14.38
Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (1977) 12.57
The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer (2006) 11.49
A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res (2010) 11.42
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst (1973) 11.26
Retracted Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science (2009) 10.76
A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst (1973) 10.64
Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst (1972) 10.15
Retracted Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog (2006) 10.08
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res (1988) 9.96
CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. Cancer (1965) 8.54
Classification of human colorectal adenocarcinoma cell lines. Cancer Res (1976) 7.00
Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol (1979) 6.96
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A (1976) 6.82
Induction of murine C-type viruses from clonal lines of virus-free BALB-3T3 cells. Science (1971) 6.71
Breast tumor cell lines from pleural effusions. J Natl Cancer Inst (1974) 5.39
Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res (1985) 5.02
Leukemogenic activity of filtrates from radiation-induced lymphoid tumors of mice. Science (1959) 4.97
tRNAdb 2009: compilation of tRNA sequences and tRNA genes. Nucleic Acids Res (2008) 4.88
An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A (2007) 4.77
Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro (1978) 4.67
A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum. Proc Natl Acad Sci U S A (1973) 4.55
Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science (1990) 4.28
Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer (1978) 4.04
MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat (2006) 4.04
Recombinant origin of the retrovirus XMRV. Science (2011) 3.54
Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res (2003) 3.42
Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer (1979) 3.37
Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Natl Cancer Inst (1977) 3.35
Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J Virol (2009) 3.16
Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res (1981) 3.12
Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology (2010) 2.90
Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res (1983) 2.90
Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem (1986) 2.88
Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology (2010) 2.75
NCI series of cell lines: an historical perspective. J Cell Biochem Suppl (1996) 2.75
Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol (1981) 2.65
Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med (1967) 2.47
In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res (1988) 2.36
Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet (2007) 2.33
Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res (1986) 2.30
Specific hybridization probes demonstrate fewer xenotropic than mink cell focus-forming murine leukemia virus env-related sequences in DNAs from inbred laboratory mice. J Virol (1986) 2.08
Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res (1985) 2.06
N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res (1979) 2.05
Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. Cancer Res (1978) 1.86
Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. Virology (2003) 1.77
Diverse wild mouse origins of xenotropic, mink cell focus-forming, and two types of ecotropic proviral genes. J Virol (1987) 1.77
Genetic analysis of endogenous xenotropic murine leukemia viruses: association with two common mouse mutations and the viral restriction locus Fv-1. J Virol (1989) 1.64
Organization and stability of endogenous xenotropic murine leukemia virus proviral DNA in mouse genomes. J Virol (1983) 1.57
Isolation of two human tumor epithelial cell lines from solid breast carcinomas. J Natl Cancer Inst (1978) 1.55
Leukemia virus activation in chronic allogeneic disease. Proc Natl Acad Sci U S A (1970) 1.55
A novel sequence segment and other nucleotide structural features in the long terminal repeat of a BALB/c mouse genomic leukemia virus-related DNA clone. Nucleic Acids Res (1983) 1.51
Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches. Semin Oncol (1984) 1.41
Xenotropic murine leukemia virus-related gammaretrovirus in respiratory tract. Emerg Infect Dis (2010) 1.40
Mouse leukemia virus activation by chemical carcinogens. Science (1969) 1.36
The mouse "xenotropic" gammaretroviruses and their XPR1 receptor. Retrovirology (2010) 1.35
Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. Int J Cancer (1990) 1.35
Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro. Cancer Res (1980) 1.31
Nucleotide sequence analysis of endogenous murine leukemia virus-related proviral clones reveals primer-binding sites for glutamine tRNA. J Virol (1985) 1.28
Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells. Cancer Res (1982) 1.25
Leukemogenic activity of centrifugates from irradiated mouse thymus and bone marrow. Int J Cancer (1966) 1.25
Structure and distribution of endogenous nonecotropic murine leukemia viruses in wild mice. J Virol (1998) 1.23
Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines. PLoS One (2011) 1.22
A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX. Int J Cancer (1988) 1.21
Highly efficient induction of type C retroviruses by a human tumor in athymic mice. Proc Natl Acad Sci U S A (1980) 1.11
Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res (1990) 1.07
Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts. Cancer Biol Ther (2011) 1.06
Infectious murine type-C viruses released from human cancer cells transplated into nude mice. Gan (1977) 1.04
C-type virus particles in human tumours transplanted into nude mice. Br J Cancer (1976) 1.03
Response of cultured human brain tumors to nitrosoureas: correlation with clinical data. Cancer (1981) 1.00
Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects. Int J Cancer (1976) 1.00
Establishment and characterization of five cell lines derived from human malignant gliomas. Acta Neuropathol (1987) 0.98
Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15. J Natl Cancer Inst (1993) 0.96
In vitro cultivation of human renal cell cancer. I. Establishment of cells in culture. In Vitro (1976) 0.96
Species identification of animal cells by nested PCR targeted to mitochondrial DNA. In Vitro Cell Dev Biol Anim (2007) 0.95
Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res (1988) 0.91
Envelope and long terminal repeat sequences of an infectious murine leukemia virus from a human SCLC cell line: implications for gene transfer. Virus Genes (1998) 0.88
Characterization of two human cell lines (TK-10, TK-164) of renal cell cancer. Cancer Res (1987) 0.85
The tyrosine kinase sf-Stk and its downstream signals are required for maintenance of friend spleen focus-forming virus-induced fibroblast transformation. J Virol (2007) 0.83
Altered regulation of the cytochrome P4501A1 gene: novel inducer-independent gene expression in pulmonary carcinoma cell lines. J Natl Cancer Inst (1989) 0.82
Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors. Int J Cancer (1986) 0.82
Preferential metabolism of N-nitrosodiethylamine by two cell lines derived from human pulmonary adenocarcinomas. Carcinogenesis (1986) 0.81
Establishment and characterization of a cell line from a human gliosarcoma. Cancer Res (1986) 0.80
Murine type C retroviruses and intracisternal A-particles in human tumors serially passaged in nude mice. J Natl Cancer Inst (1983) 0.79
XMRV: not a mousy virus. J Formos Med Assoc (2011) 0.75
Retracted Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science (2009) 10.76
Sub-diffraction-limited optical imaging with a silver superlens. Science (2005) 7.67
Plasmon lasers at deep subwavelength scale. Nature (2009) 4.93
Three-dimensional optical metamaterial with a negative refractive index. Nature (2008) 4.87
A graphene-based broadband optical modulator. Nature (2011) 4.21
A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med (2009) 4.20
An optical cloak made of dielectrics. Nat Mater (2009) 4.16
Far-field optical hyperlens magnifying sub-diffraction-limited objects. Science (2007) 4.14
Optical negative refraction in bulk metamaterials of nanowires. Science (2008) 3.28
Ultrasonic metamaterials with negative modulus. Nat Mater (2006) 2.91
Plasmon-induced transparency in metamaterials. Phys Rev Lett (2008) 2.88
Experimental demonstration of an acoustic magnifying hyperlens. Nat Mater (2009) 2.82
c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology (2014) 2.04
Photonic spin Hall effect at metasurfaces. Science (2013) 2.04
Phase mismatch-free nonlinear propagation in optical zero-index materials. Science (2013) 1.90
Edge nonlinear optics on a MoS₂ atomic monolayer. Science (2014) 1.83
Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS One (2013) 1.81
Room-temperature sub-diffraction-limited plasmon laser by total internal reflection. Nat Mater (2010) 1.73
Switching terahertz waves with gate-controlled active graphene metamaterials. Nat Mater (2012) 1.72
Probing the electromagnetic field of a 15-nanometre hotspot by single molecule imaging. Nature (2011) 1.72
Space-time crystals of trapped ions. Phys Rev Lett (2012) 1.71
Photoinduced handedness switching in terahertz chiral metamolecules. Nat Commun (2012) 1.69
Flying plasmonic lens in the near field for high-speed nanolithography. Nat Nanotechnol (2008) 1.65
Spherical hyperlens for two-dimensional sub-diffractional imaging at visible frequencies. Nat Commun (2010) 1.61
Transformational plasmon optics. Nano Lett (2010) 1.61
Plasmonic Luneburg and Eaton lenses. Nat Nanotechnol (2011) 1.59
DISCO: distance and spectrum correlation optimization alignment for two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics. Anal Chem (2010) 1.58
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis. Blood (2009) 1.58
Double-layer graphene optical modulator. Nano Lett (2012) 1.56
A carpet cloak for visible light. Nano Lett (2011) 1.55
Negative refractive index in chiral metamaterials. Phys Rev Lett (2009) 1.55
High-Q surface-plasmon-polariton whispering-gallery microcavity. Nature (2009) 1.52
All optical interface for parallel, remote, and spatiotemporal control of neuronal activity. Nano Lett (2007) 1.49
Wavelet- and Fourier-transform-based spectrum similarity approaches to compound identification in gas chromatography/mass spectrometry. Anal Chem (2011) 1.49
Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis. Cancer Cell (2007) 1.45
Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry peak sorting algorithm. J Chromatogr A (2007) 1.42
MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin. Biochem Biophys Res Commun (2012) 1.40
Far-field optical superlens. Nano Lett (2007) 1.39
Focusing surface plasmons with a plasmonic lens. Nano Lett (2005) 1.39
Common aspects of human and primate seronegative arthritis. J Rheumatol (2004) 1.39
Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am J Pathol (2012) 1.37
Performance evaluation of existing de novo sequencing algorithms. J Proteome Res (2006) 1.36
Metamaterials: a new frontier of science and technology. Chem Soc Rev (2011) 1.34
Compound identification using partial and semipartial correlations for gas chromatography-mass spectrometry data. Anal Chem (2012) 1.34
Light-driven nanoscale plasmonic motors. Nat Nanotechnol (2010) 1.33
Observation of stimulated emission of surface plasmon polaritons. Nano Lett (2008) 1.32
Maskless plasmonic lithography at 22 nm resolution. Sci Rep (2011) 1.31
Cloaking of matter waves. Phys Rev Lett (2008) 1.28
A method of calculating the second dimension retention index in comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry. J Chromatogr A (2011) 1.28
A method of finding optimal weight factors for compound identification in gas chromatography-mass spectrometry. Bioinformatics (2012) 1.27
Axon initiation and growth cone turning on bound protein gradients. J Neurosci (2009) 1.27
Strong coupling of surface plasmon polaritons in monolayer graphene sheet arrays. Phys Rev Lett (2012) 1.27
Self-amplifying autocrine actions of BDNF in axon development. Proc Natl Acad Sci U S A (2011) 1.25
MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin. FEBS Lett (2012) 1.22
An optimal peak alignment for comprehensive two-dimensional gas chromatography mass spectrometry using mixture similarity measure. Bioinformatics (2011) 1.22
Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res (2005) 1.21
Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province, China. Trop Med Int Health (2007) 1.21
Roles of GRP78 in physiology and cancer. J Cell Biochem (2010) 1.20
Subwavelength discrete solitons in nonlinear metamaterials. Phys Rev Lett (2007) 1.20
MetSign: a computational platform for high-resolution mass spectrometry-based metabolomics. Anal Chem (2011) 1.19
Measuring financial protection for health in families with chronic conditions in Rural China. BMC Public Health (2012) 1.18
Neural network prediction of peptide separation in strong anion exchange chromatography. Bioinformatics (2006) 1.17
Passivation mechanism of thermal atomic layer-deposited Al2O3 films on silicon at different annealing temperatures. Nanoscale Res Lett (2013) 1.15
The effect of nonsense codons on splicing: a genomic analysis. RNA (2003) 1.15
Integrative biological analysis of the APOE*3-leiden transgenic mouse. OMICS (2004) 1.13
Development of optical hyperlens for imaging below the diffraction limit. Opt Express (2007) 1.13
Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas. Cancer (2005) 1.12
Nonparaxial Mathieu and Weber accelerating beams. Phys Rev Lett (2012) 1.11
iMatch: a retention index tool for analysis of gas chromatography-mass spectrometry data. J Chromatogr A (2011) 1.11
A hierarchical statistical model to assess the confidence of peptides and proteins inferred from tandem mass spectrometry. Bioinformatics (2007) 1.11
How powerful is CD133 as a cancer stem cell marker in brain tumors? Cancer Treat Rev (2009) 1.10
Environmental epigenetics and its implication on disease risk and health outcomes. ILAR J (2012) 1.10
Health-related quality of life in patients with high-grade glioma. Neuro Oncol (2008) 1.10
Partial retraction. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science (2011) 1.10
Heterojunction silicon microwire solar cells. Nano Lett (2012) 1.10
New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy. Cancer Biol Ther (2007) 1.09
Multiplexed and electrically modulated plasmon laser circuit. Nano Lett (2012) 1.08
Expression of androgen receptor is negatively regulated by p53. Neoplasia (2007) 1.08
Methods for the differential integrative omic analysis of plasma from a transgenic disease animal model. OMICS (2004) 1.08
Plasmonic Airy beams with dynamically controlled trajectories. Opt Lett (2011) 1.07
Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15. Transl Oncol (2009) 1.06
Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease. J Proteome Res (2012) 1.06
MetPP: a computational platform for comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics. Bioinformatics (2013) 1.06
Exacerbation of diabetes-induced testicular apoptosis by zinc deficiency is most likely associated with oxidative stress, p38 MAPK activation, and p53 activation in mice. Toxicol Lett (2010) 1.05
Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. J Vasc Surg (2008) 1.05
Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci (2006) 1.04
Recent advances in transformation optics. Nanoscale (2012) 1.04
Experimental certification of random numbers via quantum contextuality. Sci Rep (2013) 1.04
Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathways. Brain Res (2010) 1.03
HTreeQA: Using Semi-Perfect Phylogeny Trees in Quantitative Trait Loci Study on Genotype Data. G3 (Bethesda) (2012) 1.03
An optical "Janus" device for integrated photonics. Adv Mater (2010) 1.03
Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma. J Neurooncol (2007) 1.02
Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling. J Invest Dermatol (2010) 1.01
Optical forces in hybrid plasmonic waveguides. Nano Lett (2011) 1.01
Ultrafast modulation of optical metamaterials. Opt Express (2009) 1.01
Symmetry breaking and optical negative index of closed nanorings. Nat Commun (2012) 1.01
Data preprocessing method for liquid chromatography-mass spectrometry based metabolomics. Anal Chem (2012) 1.01
Comparative analysis of mass spectral matching-based compound identification in gas chromatography-mass spectrometry. J Chromatogr A (2013) 1.00